LAVA Therapeutics NV Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Lava Therapeutics NV |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
LAVA Therapeutics NV filed its 2024 10-K. Financials for 2022-2024 detailed.
AI Summary
LAVA Therapeutics NV filed its 2024 10-K on March 28, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in P7, operates in the Pharmaceutical Preparations sector. Key financial data such as Retained Earnings, Additional Paid-In Capital, and Accumulated Other Comprehensive Income for the years 2022, 2023, and 2024 are detailed within the filing.
Why It Matters
This filing provides investors with a comprehensive overview of LAVA Therapeutics NV's financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, LAVA Therapeutics NV is subject to significant regulatory, research, and market risks inherent in drug development and commercialization.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (Comparative financial data)
- 2022 — Prior Fiscal Year (Comparative financial data)
Key Players & Entities
- LAVA Therapeutics NV (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 20250328 (date) — Filing date
- 0001840748 (company) — Central Index Key
- 2834 (industry) — Standard Industrial Classification (Pharmaceutical Preparations)
- UTRECHT (location) — Business and Mail Address City
- 001-40241 (company) — SEC File Number
FAQ
What is LAVA Therapeutics NV's primary business activity?
LAVA Therapeutics NV operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 28, 2025.
What is the fiscal year end for LAVA Therapeutics NV?
The fiscal year end for LAVA Therapeutics NV is December 31.
What are some key financial statement components reported for 2024?
The filing details Retained Earnings, Additional Paid-In Capital, and Accumulated Other Comprehensive Income for the year ended December 31, 2024.
Where is LAVA Therapeutics NV headquartered?
LAVA Therapeutics NV's business and mail address is located in Utrecht.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding LAVA Therapeutics NV.